Eyetech Pharmaceuticals Report issue

Contributed to NME For profit Phase 4
Founded: New York NY United States (1997)
Status: Acquired by Bausch Health Companies (2012)

Organization Overview

First Clinical Trial
2001
NCT00321997
First Marketed Drug
2004
pegaptanib (macugen)
First NDA Approval
2004
pegaptanib (macugen)
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Eyetech Pharmaceuticals